Physician profile
Ian Klein
NPI 1033118187
$2,468.14
in general payments reported to CMS, 2019-2025
11 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $76.57 · 2021: $555 · 2022: $317 · 2023: $601 · 2024: $443 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $669.08 | 2019-2023 | Physio-Stim, Spinal-Stim |
| Horizon Therapeutics Plc | $394.17 | 2021-2022 | |
| Convatec INC. | $240.55 | 2023-2024 | |
| Organogenesis INC. | $208.83 | 2021-2023 | Puraply Antimicrobial |
| Smith+Nephew, INC. | $200.63 | 2019-2021 | |
| Inari Medical, INC. | $182.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biopro, INC. | $163.85 | 2023 | |
| Forma Medical | $146.66 | 2025 | Optimalmtp |
| Linvatec Corporation | $137.56 | 2024 | Biobrace 23mm |
| Merck Sharp & Dohme LLC | $108.97 | 2019 | |
| Pfizer INC. | $14.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.